Development of a hemicornea from human primary cell cultures for pharmacotoxicology testing

Cell Biology and Toxicology

Volumn 23, Issue 4, 2007, Pages 279-292

  Builles, N ^a   Bechetoille, N ^b   Justin, V ^a   Andre V ^b   Barbaro, V ^c   Di Iorio, E ^c   Auxenfans, C ^a   Hulmes, D J S ^d   Damour, O ^a,d,e  

^a HOSPICES CIVILS DE LYON   (France)

^b France   (France)

^c The Veneto Eye Bank Foundation   (Italy)

^d CNRS   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Cornea; Hemicornea; Pharmacotoxicology; Three dimensional model; Tissue engineering

Indexed keywords

CHITOSAN; COLLAGEN FIBRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; CYTOKERATIN; CYTOKERATIN 3; GLYCOSAMINOGLYCAN; KALININ; PROTEIN 14 3 3; PROTEIN P63; UNCLASSIFIED DRUG;

BASEMENT MEMBRANE; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CORNEA CELL; CORNEA STROMA; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; HEMIDESMOSOME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMAL TESTING ALTERNATIVES; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLLAGEN TYPE IV; CORNEA; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; EXTRACELLULAR MATRIX; HEMIDESMOSOMES; HUMANS; MEMBRANE PROTEINS; STEM CELLS; STROMAL CELLS;

ANIMALIA;

EID: 33947493268     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-006-0191-0     Document Type: Conference Paper

References (41)

1. Augustin C, Collombel C, Damour O. Use of in vitro dermal equivalent and skin equivalent kits for evaluating cutaneous toxicity of cosmetics products. In Vitro Toxicol. 1997a;1:21.
2. Augustin C, Collombel C, Damour O. Measurments of the protective effect of topically applied sunscreens unsing in vitro three-dimensional dermal and skin equivalents. Photochem Photobiol. 1997b;66:853-9.
3. Augustin C, Frei V, Perrier E, Huc A, Damour O. A skin equivalent model for cosmetological trials: an in vitro study of a new biopeptide. Skin Pharmacol. 1997c;10:63-70.
4. Augustin C, Frei V, Perrier E, Huc A, Damour O. An in vitro selection of new cosmetic active compounds: from screening tests on fibroblast monolayered culture to efficacy study on dermal equivalent. J Appl Cosmetol. 1997d;15:1.
5. Augustin C, Collombel C, Damour O. Use of in vitro dermal equivalent and skin equivalent models for identifying phototoxic compounds in-vitro. Photodermatol Photoimmunol Photomed. 1997e;13:27-36.
6. Balls M, Berg N, Bruner LH, et al. Eye irritation testing: the way forward. The report and recommendations of ECVAM workshop 34. Altern Lab Anim 1999;27:53-77.
7. Bell E, Ivarson B, Merril C. Production of a tissue like structure by contraction of collagen lattice by human fibroblast of different proliferative potential in vitro. Proc Natl Acad Sci USA. 1979;76:1274-78.
8. Black AF, Bouez C, Perrier E, Schlotmann K, Chapuis F, Damour O. Optimization and characterization of an engineered human skin equivalent. Tissue Eng. 2005;11:723-33.
9. Collombel C, Damour O, Gagnieu C, Marichy J, Poinsignon F. Biomaterials with a base of collagen, chitosan and glycosaminoglycans; process for preparing them and their application in human medicine. French patent 8708252, 1987. European patent 884101948, 1988. US patent PCT/FR/8800303, 1989.
10. Curren RD, Harbell JW. In vitro alternatives for ocular irritation. Environ Health Perspect. 1998;106:485-92.
11. Curren RD, Harbell JW. Ocular safety: a silent (in vitro) success story. Altern Lab Anim 2002;30(Supplement 2):69-74.
12. Damour O, Augustin C, Black A. Application of reconstructed skin models in pharmacotoxicological trials. Med Biol Eng Comput. 1998;36(6):825-32.
13. Dellambra E, Golisano O, Bondanza S, et al. Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol. 2000;149:1117-30.
14. Di Iorio E, Barbaro V, Ruzza A, Ponzin D, Pellegrini G, De Luca M. Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc Natl Acad Sci USA. 2005;102(27):9523-8.
15. Dirk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2001;32:223-37.
16. Doucet O, Lanvin M, Zastrow L. A new in vitro human epithelium model for assessing the eye irritation potential of formulated cosmetic products. In Vitro Mol Toxicol. 1998;11:273-80.
17. Doucet O, Lanvin M, Thillou C, et al. Reconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic products. Toxicology In Vitro. 2005;20(4):499-512.
18. Doughty MJ. A descriptive and quantitative study of the keratocytes of the corneal stroma of albino rabbits using transmission electron microscopy. Tissue Cells. 2001;33(4):408-22.
19. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377-90.
20. Germain L, Carrier P, Auger F, Salesse C, Gúerin S. Can we produce a human corneal equivalent by tissue engineering? Prog Retin Eye Res. 2000;19(5):497-527.
21. Griffith M, Osborn R, Munger R, et al. Functional human corneal equivalents constructed from cell lines. Science, 1999;286:2169-72.
22. Hirsch M, Prenant G, Renard G. Three dimensional supramolecular organization of the extracellular matrix in human and rabbit corneal stroma as revealed by ultrarapid freezing and deep etching methods. Exp Eye Res. 2001;72:123-35.
23. Howell SJ, Doane KJ. Type VI collagen increases cell survival and prevents anti-β1 integrin mediated apoptosis. Exp Cell Res. 1998;24:230-41.
24. Kinoshita S, Adachi W, Sotozono C, et al. Characteristics of the human ocular surface epithelium. Prog Retin Eye Res. 2001;20:639-73.
25. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-6.
26. Li F, Carlsson D, Lohmann C, et al. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci USA. 2003;100(26):15346-51.
27. Liu Y, Gan L, Carlsson DJ, et al. Simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci. 2006;47:1869-75.
28. Minamitani T, Ikura T, Saito Y, et al. Modulation of collagen fibrillogenesis by tenascin X and type VI collagen. Exp Cell Res. 2004;298:305-15.
29. OECD. Test Guideline 405, adopted 24 April 2002.Paris: OECD.
30. Osborne R, Perkins MA, Roberts DA. Development and intralaboratory evaluation of an in vitro human cell-based test to aid ocular irritancy assessments. Fundam Appl Toxicol. 1995;28:139-53.
31. Pellegrini G, Golisano O, Paterna P, et al. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol. 1999;145:769-82.
32. Pellegrini G, Dellambra E, Golisano O, et al. P63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA. 2001;98:3156-61.
33. Robert L, Legeais JM, Robert AM, Renard G. Corneal collagens. Pathol Biol. 2001;49:353-63.
34. Rompre P, Auger FA, Germain L, et al. Influence of initial collagen and cellular concentrations on the final surface area of dermal and skin equivalents: a Box-Behnken analysis. In Vitro Cell Dev Biol. 1990;26(10): 983-90.
35. Shahabeddin L, Damour O, Berthod F, Rousselle P, Saintiguy G, Collombel C. Reconstructed skin from cocultured human keratinocytes and fibroblasts on a chitosan cross-linked collagen-GAG matrix. J Mater Sci Mater Med. 1991;2:222.
36. SCCNFP. Notes of guidance for testing of cosmetic ingredients for their safety evaluation. The registration, evaluation, authorisation and restrictions of chemicals (REACH). Consulting document, 2003, Volume II. Commission of the European Union.
37. Stern M, Klausner M, Alvarado R, Renskers K, Dickens M. Evaluation of EpiOcular™ tissue model as an alternative to the Draize eye irritation test. Toxicol In Vitro. 1998;12:455-61.
38. Van Goethem F, Adriaens E, Aĺeṕee N, et al. Prevalidation of a new in vitro reconstituted human cornea model to assess the eye irritating potential of chemicals. Toxicol In Vitro. 2006;20:1-17.
39. Weil CS, Scala A. Study of intra- and interlaboratory variability in the results of rabbit eye and skin irritation tests. Toxicol Appl Pharmacol. 1971;19:276-360.
40. Wilhelmus KR. The Draize eye test. Surv Ophthalmol. 2001;45:493-515.
41. Worth A, Balls M. Local toxicity: acute dermal and ocular effect In: Alternative (non-animal) methods for chemical testing: current status and future prospects - A report prepared by ECVAM and ECVAM Working Group on Chemicals edited by Andrew Worth and Mickael Balls. Altern Lab Anim. 2002;30(Supplement 1):125.